Mitochondrial Disorders Completed Phase 2 Trials for Sonlicromanol (DB16333)

Also known as: Mitochondrial Diseases / Mitochondrial Disease

IndicationStatusPhase
DBCOND0047871 (Mitochondrial Disorders)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04165239The KHENERGYZE StudyTreatment
NCT02909400The KHENERGY StudyTreatment